Significant Holter pause (sinus pause)
A sinus pause is defined as sinus node depolarization occurring more than 3 seconds after the last atrial depolarization. [1] A pause duration greater than 3 seconds alone should not be used to diagnose sinus node dysfunction. [1] Clinical decision-making for prolonged pauses should focus on symptom correlation and reversible causes. [1]
Pause definitions relevant to Holter interpretation
- Sinus pause is defined as sinus node depolarizes more than 3 seconds after the last atrial depolarization. [1]
- Sinus node arrest is defined as no evidence of sinus node depolarization. [1]
- Symptomatic bradyarrhythmia is defined as a documented bradyarrhythmia directly responsible for syncope or presyncope, transient dizziness or lightheadedness, heart failure symptoms, or confusional states due to cerebral hypoperfusion from slow heart rate. [1]
Symptom correlation and initial evaluation
A 12-lead electrocardiogram is recommended when bradycardia or a conduction disorder is suspected. [1] Cardiac rhythm monitoring is recommended to establish correlation between heart rate or conduction abnormalities with symptoms. [1] For daily symptoms, 24- or 48-hour continuous ambulatory ECG (Holter monitor) is appropriate. [1]
Evaluation for potentially reversible causes
In symptomatic patients with sinus node dysfunction, evaluation and treatment of reversible causes are recommended. [1] Potentially reversible causes of bradycardia attributable to sinus node dysfunction include acute myocardial infarction, atrial tachyarrhythmias, electrolyte abnormalities, hypothyroidism, medications, infections, and metabolic abnormalities. [1] Ambulatory evaluation for bradycardia should include medication review and assessment for conditions that can suppress sinus node automaticity. [1]
Medication selection algorithm for management of confirmed symptomatic sinus node dysfunction
Permanent pacemaker therapy decisions should be based on the presence of symptoms attributable to bradycardia and the presence or absence of reversible or physiologic causes. [1] Therapy for symptomatic sinus node dysfunction includes:
- Atrial-based pacing approaches (preferred over single-chamber ventricular pacing) for persistent symptomatic sinus node dysfunction. [1]
- Oral theophylline for symptomatic patients in whom pacing is not pursued or not feasible. [1]
Monotherapy versus combination therapy
Symptomatic sinus node dysfunction should be managed with a pacing strategy when symptomatic bradyarrhythmia persists after exclusion of reversible causes. [1] In patients unwilling to undergo permanent pacemaker implantation or not candidates for permanent pacing, oral theophylline can be considered as medical therapy instead of pacing. [1] Rate- or rhythm-modifying medications associated with bradycardia should be addressed through treatment of reversible causes rather than continued indefinitely without reassessment of symptom-rhythm correlation. [1]
Initiation thresholds and decision points
No minimum pause duration establishes an automatic indication for permanent pacing in sinus node dysfunction. [1] Permanent pacing for sinus node dysfunction is recommended in symptomatic patients with sinus node dysfunction when a reversible or physiologic cause is not identified or does not resolve. [1] For patients presenting with suspected sinus node dysfunction, the initial evaluation algorithm includes assessment for structural heart disease, exercise ECG testing when exercise-related symptoms are present, and ambulatory ECG monitoring to correlate symptoms with rhythm. [1]
Common pitfalls to avoid
A prolonged pause duration greater than 3 seconds alone should not be used to diagnose sinus node dysfunction. [1] Direct attribution of symptoms to sinus node dysfunction should always be sought because symptom attribution can be difficult. [1]
Target outcomes of therapy
The therapeutic goal is symptom improvement by addressing bradyarrhythmia-related cerebral hypoperfusion and related clinical manifestations. [1] For pacing strategies in symptomatic sinus node dysfunction, atrial-based pacing is recommended over single chamber ventricular pacing to guide long-term symptom control. [1]
Practical pacing approach for symptomatic sinus node dysfunction
In symptomatic patients with sinus node dysfunction, atrial-based pacing is recommended over single chamber ventricular pacing. [1] In symptomatic patients with sinus node dysfunction and intact atrioventricular conduction without evidence of conduction abnormalities, dual chamber or single chamber atrial pacing is recommended. [1] In symptomatic patients with sinus node dysfunction with dual chamber pacemakers and intact atrioventricular conduction, programming to minimize ventricular pacing is reasonable. [1] In symptomatic patients with sinus node dysfunction in which frequent ventricular pacing is not expected or the patient has significant comorbidities likely to determine survival and clinical outcomes, single chamber ventricular pacing is reasonable. [1]
Medical therapy option when pacing is not pursued
A trial of oral theophylline may be considered to help correlate symptoms with bradycardia. [1] In a randomized study of patients with symptomatic sinus node dysfunction, permanent pacing was superior for symptom control compared with theophylline. [1] In patients unwilling to undergo permanent pacemaker implantation or not candidates for permanent pacing, oral theophylline could be considered for treatment of symptomatic sinus node dysfunction. [1]